Chemoinformaics analysis of Dihydro-beta-ionone oxime
| Molecular Weight | 209.333 | nRot | 2 |
| Heavy Atom Molecular Weight | 186.149 | nRig | 8 |
| Exact Molecular Weight | 209.178 | nRing | 1 |
| Solubility: LogS | -4.617 | nHRing | 0 |
| Solubility: LogP | 3.827 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 38.9482 |
| nHD | 1 | BPOL | 23.0738 |
| QED | 0.418 |
| Synth | 3.943 |
| Natural Product Likeliness | 1.994 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.783 |
| MDCK | 0.0000263 |
| BBB | 0.962 |
| PPB | 0.955878 |
| VDSS | 3.245 |
| FU | 0.0401524 |
| CYP1A2-inh | 0.186 |
| CYP1A2-sub | 0.14 |
| CYP2c19-inh | 0.246 |
| CYP2c19-sub | 0.741 |
| CYP2c9-inh | 0.462 |
| CYP2c9-sub | 0.527 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.644 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.397 |
| CL | 1.35 |
| T12 | 0.211 |
| hERG | 0.022 |
| Ames | 0.032 |
| ROA | 0.467 |
| SkinSen | 0.821 |
| Carcinogencity | 0.815 |
| EI | 0.406 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.782656 |